• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, August 27, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

A new fluorescent probe that can distinguish B cells from T cells

Bioengineer by Bioengineer
April 13, 2021
in Biology
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Unlike traditional antibody-based fluorescent staining methods, the new dye directly binds to the cell membranes of the target cells

IMAGE

Credit: Institute for Basic Science

Human blood contains several different components, including plasma, red blood cells (RBCs), white blood cells (WBCs), and platelets. Among these, WBCs are divided into numerous subcategories each with unique functions and characteristics, such as lymphocytes, monocytes, neutrophils, and others. Lymphocytes are further subdivided into T lymphocytes, B lymphocytes, and NK cells. Distinguishing and separating different types of these cells is highly important in carrying out studies in the field of immunology.

Discriminating different immune cell types is typically done by flow cytometry and fluorescence-activated cell sorting (FACS), which can identify distinct populations of cells according to their size, granularity, and fluorescence. While size and granularity alone cannot distinguish cells with similar physical parameters, different types of immune cells display a distinct combination of immune receptors on the cell surfaces. For example, the T lymphocytes and B lymphocytes express CD3 and CD19, respectively. Therefore, fluorescently identifying immune cells have relied on staining the cells using multiple antibodies against different receptors. It has been long thought that it was impossible to distinguish different immune cell types without using these antibodies.

However, novel breakthrough research performed by the scientists at the Center for Self-assembly and Complexity within the Institute for Basic Science, South Korea, may have just changed this. The researchers employed a diversity oriented fluorescence library approach (DOFLA) to screen over 10,000 different fluorescent molecules using the B and T lymphocytes separated from mouse spleens. From this, they managed to discover a new fluorescent probe that can discriminate B lymphocytes over T lymphocytes without the cell receptor targeting antibodies.

The researchers called the new probe CDgB, which stands for Compound of Designation green for B lymphocytes. CDgB is a lipophilic molecule that contains a fluorescent component attached to a hydrocarbon chain. As CDgB contains both a polar fluorescent group and a hydrocarbon tail, it means that the free unbound CDgB dye molecules form aggregates similar to micelles in the solution and exhibit a low level of background fluorescence. When they attach to the cell surfaces, however, the aggregates dissociate and cause a spike in fluorescence signals. In addition, the lipophilic nature of the dye means that the dye does not bind to a protein target, and instead localizes to the lipid membrane structure directly. According to the researchers, this was “the first example to report such type of cell distinction mechanism.”

The CDgB is able to selectively target the cell membranes of B lymphocytes over T lymphocytes or NK cells. The researchers sought to optimize the selectivity of the CDgB by testing different derivatives of the molecules with various hydrocarbon chain lengths from 4 to 20 carbons. It was found that the CDgB derivatives with 14 to 18 carbons showed the highest selectivity towards the B lymphocytes, with C18 showing the best results. It became more difficult to distinguish the cells through fluorescence when the carbon length was increased beyond 20. The fact that carbon length matters in the selectivity hinted that the mechanism was dependent on the difference in the membrane structures between B and T lymphocytes.

The researchers further elucidated this mechanism by performing lipidomic analysis of B and T cell membranes. Phosphatidylcholine (PC) comprises the majority (> 60%) of the membrane phospholipids of both B and T lymphocytes. It was found that B lymphocytes in general had shorter PC’s than that of the T lymphocytes. In addition, the membrane cholesterol content in the T lymphocytes was about twice higher than that of B lymphocytes. These factors give the B lymphocytes a more ‘flexible’ cell membrane, which was thought to be a crucial factor that explains why the CDgB molecules attach more readily to the cell membranes of the B lymphocytes over those of the T lymphocytes. Even among the B lymphocytes, it was found that the strength of the fluorescence was different based on the cell maturity. The B cell progenitors and immature B cells gave off much brighter fluorescence signals than mature B cells, which is most likely due to the higher membrane flexibility in the immature cells.

The researchers furthermore concluded that this new lipid oriented live cell distinction (LOLD) mechanism can supplement the existing cell distinction mechanism to improve our ability to distinguish specific cell types from complicated mixtures of different cells. This research was published in the Journal of the American Chemical Society.

###

Media Contact
William I. Suh
[email protected]

Related Journal Article

http://dx.doi.org/10.1021/jacs.1c00944

Tags: BiologyBiomedical/Environmental/Chemical EngineeringBiotechnologyImmunology/Allergies/Asthma
Share12Tweet8Share2ShareShareShare2

Related Posts

METTL3-Driven m6A Boosts Sorafenib’s Antitumor Effects

METTL3-Driven m6A Boosts Sorafenib’s Antitumor Effects

August 27, 2025
blank

Immune Cells in the Brain: Crucial Architects of Adolescent Neural Wiring

August 26, 2025

Dihydromyricetin Shields Against Spinal Cord Injury Damage

August 26, 2025

Key Genes Identified in Nutrient Stress During Virus Infection

August 26, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    148 shares
    Share 59 Tweet 37
  • Molecules in Focus: Capturing the Timeless Dance of Particles

    142 shares
    Share 57 Tweet 36
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    115 shares
    Share 46 Tweet 29
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    81 shares
    Share 32 Tweet 20

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

METTL3-Driven m6A Boosts Sorafenib’s Antitumor Effects

Blood and Fluid Signatures Predict IVF Embryo Success

Enhancing 3D-Printed Biphasic Scaffolds with Hourglass Design

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.